investigating the utility of clinical outcome-guided mutual information network in network-based cox...
TRANSCRIPT
![Page 1: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/1.jpg)
Investigating the utility of clinical outcome-guided mutual information network in
network-based Cox regression
Hyun-hwan Jeong, So Yeon Kim, Kyubum Wee, Kyung-Ah Sohn
Department of Information and Computer Engineering, Ajou University
![Page 2: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/2.jpg)
Outline
• Motivation
• Methods
• Results
• Conclusions
1
![Page 3: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/3.jpg)
MOTIVATION
2
![Page 4: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/4.jpg)
Cox regression model (Cox, 1972) (1/2)
• Commonly used model in survival analysis
– Proportional hazard model
– Parameters estimation using partial log-likelihood
• Pros and Cons
– Pros: able to handle censored patients
– Cons: not feasible for a situation when 𝑝 ≫ 𝑛
3
![Page 5: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/5.jpg)
Cox regression model (Cox, 1972) (2/2)
• Several variants of Cox model proposed to resolve this issue
– 𝐿1-regularization (Tibshirani, 1997)
– 𝐿2-regularization in Hibert space (Li and Luan, 2002)
• However, these models are still prone to noise and over-fitting to the small 𝑝
– The models consider only marginal effects for each individual feature
4
![Page 6: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/6.jpg)
A solution – use of prior information
• Network based Cox regression (Net-Cox) (Zhang et al., 2013)
– An extension of 𝐿2-Cox regression
– Network regularization in penalized term which reflects effect of interactions of pairwise features
5
![Page 7: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/7.jpg)
Our first investigation
• Two types of network used in Zhang et al.’s study
– Co-expression network
– Functional linkage network
• A potential limitation of these networks
– No considerations of the association between features and outcomes
• Our assumption
– “network which reflects the association may improve the prediction performance”
6
![Page 8: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/8.jpg)
Summary of this study
• Applying outcome-guided mutual information network into Net-Cox
• Prediction power comparison of different types of network
• Demonstrating the utility of the network for three genomic profiles of ovarian cancer patients in TCGA
7
![Page 9: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/9.jpg)
METHODS
1. Overview of survival analysis
2. Outcome-guided network construction
3. Applying outcome-guided mutual information to Net-Cox
8
![Page 10: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/10.jpg)
Data preparationAnalysis using
a survival modelPrediction & detection
Overview of survival analysis for genomic profile
9
![Page 11: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/11.jpg)
Data preparationAnalysis using
a survival modelPrediction & detection
Overview of survival analysis for genomic profile
10
Information of Patients• For 𝑛 patients over 𝑝 genes• Three types of information
expression profile - 𝑋 ∈ ℝ𝑛×𝑝
follow-up time - 𝑡 ∈ ℝ𝑝×1
observed status - 𝛿 ∈ 0,1 𝑝×1
![Page 12: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/12.jpg)
Data preparationAnalysis using
a survival modelPrediction & detection
Overview of survival analysis for genomic profile
11
Estimation• baseline hazard - ℎ0(𝑡𝑖)• Regression coefficient - 𝛽
Model selection• Propositional hazard model - ℎ(𝑡|𝑋)
![Page 13: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/13.jpg)
Data preparationAnalysis using
a survival modelPrediction & detection
Overview of survival analysis for genomic profile
12
Prediction of survivability Detection of important features
![Page 14: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/14.jpg)
METHODS
1. Overview of survival analysis
2. Outcome-guided network construction
3. Applying outcome-guided mutual information to Net-Cox
13
![Page 15: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/15.jpg)
Construction of the outcome-guided mutual information networks (1/2)
• Mutual information
– An association measure in information theory• based on Shannon’s entropy.
• able to measure linear/non-linear association measure between two random variables.
– The measure widely used in GWAS to measure strength of association between SNPs and traits. (Leem et al. 2014, Hu et al. 2011)
𝐼 𝑋1, 𝑋2; 𝑌 = 𝐻 𝑋1, 𝑋2 + 𝐻 𝑌 − 𝐻(𝑋1, 𝑋2, 𝑌)
pair of genomic features
binary outcomes
14
![Page 16: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/16.jpg)
Construction of the outcome-guided mutual information networks (2/3)
• Two parameters - 𝜃 and 𝜎
mutual information
𝜃
# o
f ed
ges
θ = 𝑚𝑎𝑥𝑖≠𝑗 𝐼avg 𝑖, 𝑗
𝐼avg 𝑖, 𝑗 =1
30
𝑝=1
30
𝐼avg 𝑔𝑖 , 𝑔𝑗; 𝑌𝑝
15
![Page 17: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/17.jpg)
Construction of the outcome-guided mutual information networks (3/3)
• Two parameters - 𝜃 and 𝜎
mutual information
𝜃 𝜃 ∗ 1 + 𝜎
# o
f ed
ges
θ = 𝑚𝑎𝑥𝑖≠𝑗 𝐼avg 𝑖, 𝑗
𝐼avg 𝑖, 𝑗 =1
30
𝑝=1
30
𝐼avg 𝑔𝑖 , 𝑔𝑗; 𝑌𝑝
16
![Page 18: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/18.jpg)
Construction of the outcome-guided mutual information networks (3/3)
• Two parameters - 𝜃 and 𝜎
mutual information
𝜃 𝜃 ∗ 1 + 𝜎
# o
f ed
ges
θ = 𝑚𝑎𝑥𝑖≠𝑗 𝐼avg 𝑖, 𝑗
𝐼avg 𝑖, 𝑗 =1
30
𝑝=1
30
𝐼avg 𝑔𝑖 , 𝑔𝑗; 𝑌𝑝
𝐺𝜎 = 𝑔𝑖 , 𝑔𝑗 𝑔𝑖 , 𝑔𝑗 ∈ 𝑃 𝑎𝑛𝑑 𝐼 𝑔𝑖 , 𝑔𝑗; 𝑌 ≥ 𝜃(1 + 𝜎)}
17
![Page 19: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/19.jpg)
METHODS
1. Overview of survival analysis
2. Outcome-guided network construction
3. Applying outcome-guided mutual information to Net-Cox
18
![Page 20: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/20.jpg)
Overview of Net-Cox (1/3)
19
Log-likelihood in 𝐿2-Cox
![Page 21: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/21.jpg)
Overview of Net-Cox (2/3)
20
Log-likelihood in 𝐿2-Cox+
Network regularization
![Page 22: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/22.jpg)
Overview of Net-Cox (3/3)
21
Feature network
![Page 23: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/23.jpg)
Applying outcome-guided mutual information to Net-Cox (1/2)
22
Outcome-guidedmutual information network
𝒍𝒑𝒆𝒏 𝜷, 𝒉𝟎 = 𝒍 𝜷, 𝒉𝟎 −𝟏
𝟐𝝀𝜷′[ 𝟏 − 𝜶 𝑳 + 𝜶𝑰]𝜷
• 𝐿 = 𝐼 − 𝑆 𝐼 : identity matrix 𝑆 : normalized Laplacian matrix
• 𝜆 - control parameter• α ∈ 0,1 Network contribution parameter If 𝛼 = 1, Net-Cox ≡ 𝐿2-Cox
Penalty terms
• Penalized total log-likelihood of Net-Cox
![Page 24: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/24.jpg)
Applying outcome-guided mutual information to Net-Cox (2/2)
• Definition of edge weight in 𝐺𝜎
𝐺𝜎𝑖𝑗 =𝐼 𝑔𝑖 , 𝑔𝑗; 𝑌
𝑔𝑖,𝑔𝑘∈𝐺𝜎𝐼(𝑔𝑖 , 𝑔𝑘; 𝑌) (𝑔𝑗,𝑔𝑘)∈𝐺𝜎
𝐼(𝑔𝑗 , 𝑔𝑘; 𝑌)
• Matrix normalization for Laplacian constraint
– 𝑆 = 𝑅−1
2 𝐺𝜎𝐶−1
2
• 𝑅𝑖𝑖 = 𝑗 𝐺𝜎 𝑖𝑗
• 𝐶𝑖𝑖 = 𝑗 𝐺𝜎′
𝑖𝑗
23
![Page 25: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/25.jpg)
RESULTS
24
![Page 26: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/26.jpg)
Dataset - Ovarian Cancer data in TCGA
• Measurements for 10,022 genes of 340 cancer patients in three different genomic level
• Survival month classification:– Short-term(<36 month), long-term(otherwise)
Genomic profile Platform Data Type
CNA Affymetrix SNP 6Discrete (GISTIC)
Continuous
mRNA Agilent microarray Continuous
methylation Illumina Infinium HumanMethylation27 Continuous
25
![Page 27: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/27.jpg)
Performance comparison of feature networks
• Outcome-guided mutual information network
• Co-expression network (Zhang et al. 2013)
• Functional linkage network (Zhang et al. 2013)
• Without feature network (𝐿2-Cox model)
26
![Page 28: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/28.jpg)
Best parameter selection (1/2)
• 5-fold cross validation
– 80% of samples for training and testing
– 20% of samples for validation
• Parameters
– 𝜎 = 0.00, 0.05, 0.10, 0.20, 0.25, 0.30
– 𝜆 = 10−4, 10−3, 10−2, 10−1
– 𝛼 = [0.1, 0.3, 0.5, 0.7, 0.9, 1.0]
27
![Page 29: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/29.jpg)
Best parameter selection (2/2)
• Performance measure
– time-dependent 𝐴𝑈𝐶 𝑡 𝑓 𝑋
• 𝑓 𝑋 = 𝑋′𝛽
– 𝐴𝑈𝐶[𝑡|𝑓 𝑋 ] – area under the 𝑅𝑂𝐶 𝑡 𝑓 𝑋curve
– 𝑅𝑂𝐶 𝑡 𝑓 𝑋 - sensitivity vs. 1-specificity– 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 𝑐, 𝑡 𝑓(𝑋) = Pr 𝑓 𝑋 > 𝑐 𝛿 𝑡 = 1
– 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 𝑐, 𝑡 𝑓(𝑋) = Pr 𝑓 𝑋 > 𝑐 𝛿 𝑡 = 0
28
![Page 30: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/30.jpg)
Assessment of significance
• Log-rank test for validity of the group assessment– Prognostic indices 𝑃𝐼 = 𝑋′ 𝛽
• Top 40% of patients as high-risk, bottom 40% patients as low-risk in descending order
• Network analysis– For sub-network of 100 largest coefficient genes
– Measurement of network properties
• Enrichment test for biological terms– ToppGene (https://toppgene.cchmc.org)
– Gene Ontology(GO), disease, pathway
29
![Page 31: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/31.jpg)
RESULTS
1. Cross validation & statistical assessment
2. Network analysis
30
![Page 32: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/32.jpg)
Prediction accuracy for 𝐺𝜎
31
![Page 33: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/33.jpg)
Optimal parameters for each network
32
Profile Network 𝝈 𝛌 𝛂 Mean(AUC)
CNA
Mutual Information 0.30 10−3 0.1 0.5875
Correlation - 10−3 0.9 0.5817
Functional Linkage - 10−3 0.3 0.5786
𝐿2 − Cox - 10−3 1.0 0.5810
mRNA
Mutual Information 0.10 10−4 0.1 0.6317
Correlation - 10−4 0.9 0.6280
Functional Linkage - 10−4 0.3 0.6242
𝐿2 − Cox - 10−4 1.0 0.6288
METH
Mutual Information 0.30 10−4 0.5 0.5912
Correlation - 10−4 0.7 0.5894
Functional Linkage - 10−4 0.3 0.5860
𝐿2 − Cox - 10−4 1.0 0.5899
![Page 34: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/34.jpg)
Performance comparison of different network types in validation set
33
![Page 35: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/35.jpg)
Kaplan-Meier survival curves with log-rank test
34
Mutualinformation
Co-expression network
FunctionalLinkage
𝑳𝟐-Cox
CNA mRNA METH
![Page 36: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/36.jpg)
Significant genes for each profile
35
![Page 37: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/37.jpg)
Enrichment test of 100 largest coefficient genes for each profile
36
Profile Category Name p-valueAdjustedp-value
CNA
Disease Ovarian Neoplasms 5.24E-04 2.84E-02
Disease Carcinoma 7.42E-03 3.66E-02
mRNA
GO:MF chitinase activity 4.80E-06 1.78E-03
GO:BP chitin catabolic process 4.83E-06 4.94E-03
GO:BP chitin metabolic process 4.83E-06 4.94E-03
![Page 38: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/38.jpg)
RESULTS
1. Cross validation & statistical assessment
2. Network analysis
37
![Page 39: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/39.jpg)
Sub-network with large coefficients genes for each profile
38
CNA
METH
mRNA
![Page 40: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/40.jpg)
Network properties of mutual information sub-network
39
Properties CNA mRNA METH
Nodes 78 154 149
Connected components 7 54 50
𝑹𝟐 of node degree distribution 0.672 0.922 0.909
Network centralization 0.312 0.058 0.052
Characteristic path length 2.117 2.187 2.164
Average number of neighbors 2.564 1.299 1.342
Network density 0.033 0.008 0.009
Network heterogeneity 1.383 0.828 0.809
![Page 41: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/41.jpg)
Enrichment test for each sub-network of profiles
40
Profile Category Name p-valueAdjusted
p-value
CNA
Disease Hyperlipidemias 1.76E-05 2.24E-03
Disease Obesity 1.98E-03 1.21E-02
Disease Insulin Resistance 8.96E-03 2.42E-02
Disease Neoplasms 1.05E-02 2.78E-02
mRNADisease Carcinoma 1.19E-04 1.23E-02
Disease Neoplasm Recurrence, Local 1.25E-02 4.96E-02
METH
GO:MF G-protein coupled peptide receptor activity 4.15E-05 1.21E-02
GO:MF peptide receptor activity 4.86E-05 1.21E-02
GO:MF anaphylatoxin receptor activity 1.78E-04 1.78E-02
GO:MF calcitonin receptor activity 1.78E-04 1.78E-02
GO:MF thyroxine 5'-deiodinase activity 1.78E-04 1.78E-02
![Page 42: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/42.jpg)
CONCLUSIONS
41
![Page 43: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/43.jpg)
Conclusions (1/2)
• Outcome-guided mutual information network
– Can further improve prediction performance
– The permutation testing scheme also helps the improvement
• In the analysis genomic profiles ovarian cancer patients,
– Sub-network for largest coefficient genes have network topologies of biological networks and show biological significance
42
![Page 44: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/44.jpg)
Conclusions (2/2)
• However, the proposed method shows rather marginal performance improvement.
– It seems due to a mismatch between the high mutual information value and the small value of penalty term in the Net-Cox model.
– We plan to modify of the penalty term and it will further improve of the power.
43
![Page 45: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/45.jpg)
감사합니다.
44
![Page 46: Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression](https://reader034.vdocuments.site/reader034/viewer/2022042818/55c17c67bb61eb16798b45c9/html5/thumbnails/46.jpg)
Q & A
45